0001179110-14-003194.txt : 20140220
0001179110-14-003194.hdr.sgml : 20140220
20140220155037
ACCESSION NUMBER: 0001179110-14-003194
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140218
FILED AS OF DATE: 20140220
DATE AS OF CHANGE: 20140220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WHEELER CRAIG A
CENTRAL INDEX KEY: 0001229450
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 14629473
4
1
edgar.xml
FORM 4 -
X0306
4
2014-02-18
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001229450
WHEELER CRAIG A
C/O MOMENTA PHARMACEUTICALS, INC.
675 WEST KENDALL STREET
CAMBRIDGE
MA
02142
1
1
0
0
President
Common Stock
2014-02-18
4
S
0
1687
17.96
D
320508
D
Common Stock
2014-02-18
4
A
0
70000
0
A
390508
D
Common Stock
2014-02-19
4
S
0
2110
17.86
D
388398
D
Common Stock
252106
I
Craig Wheeler revocable trust
Stock Option (Righ to Buy)
17.96
2014-02-18
4
A
0
140000
0
A
2014-05-18
2024-02-18
Common Stock
140000
1192000
D
This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on November 25, 2009.
Represents 70,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Wheeler. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 18, 2015 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
Represents an option granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria, the shares subject to such option vest as to 6.25% of the shares at the end of each three-month period following the grant date.
/s/ Eric Shaff as attorney in fact
2014-02-20